Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Asuransi Bina Dana Arta Tbk. (ABDA) vs UBC Medical Indonesia Tbk. (LABS)

Asuransi Bina Dana Arta Tbk.Trading
UBC Medical Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Asuransi Bina Dana Arta Tbk. dan UBC Medical Indonesia Tbk.: Asuransi Bina Dana Arta Tbk. diperdagangkan di Rp3.830 (kapitalisasi pasar 2,38 T, volume 24 jam 11,3 rb), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp161 (kapitalisasi pasar 635,95 M, volume 24 jam 1,34 jt). Perbedaan utamanya: Asuransi Bina Dana Arta Tbk. jauh lebih besar — sekitar 3,7× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (1,34 jt vs 11,3 rb). Mana yang lebih baik tergantung tujuan investasimu.

ABDALABS
Kapitalisasi Pasar
2,38 T635,95 M
Volume
11,3 rb1,34 jt
Lot
11313,4 rb
Perputaran
43,79 jt215,64 jt
Harga Rata-rata
3.875,49160,93
Nilai Transaksi
43,79 jt215,64 jt
Harga Ekuilibrium Indikatif
3.840161
Volume Ekuilibrium Indikatif
10017

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ABDA
Lihat detail
LABS
Lihat detail

Tentang Asuransi Bina Dana Arta Tbk.

PT Asuransi Bina Dana Arta Tbk was established at Jakarta under the name of PT Asuransi Bina Dharma Arta, as in accordance with Notarial Deed No. 78 of Kartini Mulyadi, S.H., Notary in Jakarta, dated October 12, 1982.

Selengkapnya di halaman ABDA

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS